Abstract
Diabetic nephropathy has become a worldwide epidemic, accounting for approximately one third of all cases of end-stage renal disease. With increasing prevalence of diabetes particularly in Asia, and a global prevalence of microalbuminuria of 39%, the problem is expected to grow. Improved management of diabetes aimed at improved glycemic control, to avoid initiation of diabetic nephropathy, and antihypertensive treatment blocking the renin-angiotensin system, to avoid its progression, need to be implemented, particularly in high-risk patients.
| Original language | English |
|---|---|
| Journal | Current Diabetes Reports |
| Volume | 6 |
| Issue number | 6 |
| Pages (from-to) | 479-83 |
| Number of pages | 5 |
| ISSN | 1534-4827 |
| Publication status | Published - Dec 2006 |
| Externally published | Yes |
Keywords
- Antihypertensive Agents
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Humans
- Hyperglycemia
- Incidence
- Kidney Failure, Chronic
- Journal Article
- Review
Fingerprint
Dive into the research topics of 'Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS